- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mild to Moderate COVID-19
Total 8343 results
-
Brown UniversityCompletedMild-moderate Unipolar Depression; Persistent Negative AffectUnited States
-
Centre Hospitalier Universitaire de NiceCompleted- Mild and Moderate Presbycusis (20 to 50 dB Average Hearing Loss at 500, 1000, 2000 Hz and 4000 Hz)France
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Hospices Civils de LyonCompletedto Predict an Unfavorable Evolution of Covid-19 at the Hospital Admission of PatientsFrance
-
Mesoblast International SàrlNo longer availableModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19United States
-
Institut de Sante Publique, d'Epidemiologie et...CompletedAlzheimer Disease or Associated Disorder | Mild to Moderately Severe DementiaFrance
-
Tufts Medical CenterCentocor, Inc.CompletedModerate to Severe Palmar Plantar PsoriasisUnited States
-
NovartisCompletedModerate to Severe HypertensionRussian Federation, Romania, Singapore, Spain, Germany, Philippines
-
University of California, San FranciscoCompletedModerate to Severe PsoriasisUnited States
-
Biosplice Therapeutics, Inc.CompletedModerate to Severe OsteoarthritisUnited States
-
Philipps University Marburg Medical CenterCompleted
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedMild and Moderate Renal ImpairmentRussian Federation, Germany, Serbia
-
University of VictoriaCompletedModerate Depression | Inactivity, Physical | Low Mood | Mild DepressionCanada
-
Organon and CoCompletedMild to Severe Hypertension
-
King Abdullah International Medical Research CenterRecruitingModerate Covid19Saudi Arabia
-
University of WarsawNot yet recruitingModerate Depressive Episode | Mild Depressive Episode
-
University Hospital, Basel, SwitzerlandgreenTEG AGCompletedCore Body Temperature in Healthy Subjects | Immune Response to mRNA COVID-19 VaccinationSwitzerland
-
Wolfson Medical CenterCompletedCan Milk Allergic Patients Tolerate Baked Milk ProductsIsrael
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
University of CopenhagenArla Foods; Hoeng Fonden; Bionor PharmaUnknownTo Investigate the Effect of UHT Treated Milk Versus Pasteurised Milk on Bloodlipid ProfilDenmark
-
Foresee Pharmaceuticals Co., Ltd.TerminatedSevere to Critical COVID 19 With Associated ARDSUnited States
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany
-
AcelRx Pharmaceuticals, Inc.CompletedModerate-to-severe Acute PainUnited States
-
AcelRx Pharmaceuticals, Inc.U.S. Army Medical Research and Development CommandCompletedModerate-to-severe Acute PainUnited States
-
AbbVie (prior sponsor, Abbott)IMS HealthCompletedModerate-to-severe Chronic Plaque Psoriasis
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsActive, not recruitingTricuspid Regurgitation | Mild Tricuspid Regurgitation | Moderate Tricuspid RegurgitationUnited States, Canada, Germany
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
CelltrionRecruitingModerate to Severe Chronic Plaque PsoriasisEstonia
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Astellas Pharma IncBiogenCompleted
-
Philipps University Marburg Medical CenterCompletedDepression Moderate | Depression MildGermany
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
Janssen Biotech, Inc.CompletedModerate to Severe Plaque PsoriasisUnited States